CN113144076A - Traditional Chinese medicine composition for treating myocarditis - Google Patents
Traditional Chinese medicine composition for treating myocarditis Download PDFInfo
- Publication number
- CN113144076A CN113144076A CN202110561632.5A CN202110561632A CN113144076A CN 113144076 A CN113144076 A CN 113144076A CN 202110561632 A CN202110561632 A CN 202110561632A CN 113144076 A CN113144076 A CN 113144076A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- myocarditis
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating myocarditis, which is prepared from the following raw materials in parts by weight: 3-9 parts of evergreen; 6-12 parts of dogbane leaves; 9-18 parts of achyranthes aspera and abelmoschus manihot; 15-30 parts of mistletoe. The invention has the characteristics of obvious treatment effect, short treatment period, no toxic or side effect and the like.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating myocarditis.
Background
Myocarditis refers to a disease mainly manifested by localized or diffuse inflammatory lesions of the myocardium and is classified into fulminant myocarditis, acute myocarditis, chronic active myocarditis, and chronic persistent myocarditis. Myocarditis has a wide variety of clinical manifestations ranging from asymptomatic to severe arrhythmias, acute cardiac insufficiency, cardiogenic shock and even death. No special medicine is available at present for treating myocarditis, and the treatment of myocarditis mainly comprises symptomatic auxiliary support treatment and mainly comprises active treatment of shock, heart failure, arrhythmia and other comprehensive treatments.
Disclosure of Invention
The invention aims to improve the defects of the prior art and provides the traditional Chinese medicine composition for treating myocarditis, which has the characteristics of obvious treatment effect, short treatment period, no toxic or side effect and the like.
Traditional Chinese medicine considers that myocarditis belongs to the categories of palpitation (including ancient severe palpitation) and cardiodynia. Deficiency is the root of the disease, toxicity is the important condition of the disease, and dampness, stasis and phlegm are different pathological changes in the course of the disease. Myocarditis is caused by the invasion of pathogenic wind-heat or damp-heat by the body's deficiency of healthy qi and the invasion of pathogenic factors into the heart.
Based on the theory, the technical scheme of the invention is as follows: an oral administration traditional Chinese medicine for treating myocarditis is composed of the following raw material medicines in parts by weight: 3-9 parts of evergreen; 6-12 parts of dogbane leaves; 9-18 parts of achyranthes aspera and abelmoschus manihot; 15-30 parts of mistletoe.
In a preferred embodiment, the traditional Chinese medicine composition for treating myocarditis is prepared from the following raw material medicines in parts by weight: 9 parts of evergreen; 12 parts of dogbane leaves; 18 parts of achyranthes aspera and abelmoschus manihot; 15-30 parts of mistletoe.
Wherein, the yellow hollyhock flower: sweet and cold in nature. Clear heat and remove toxicity, moisten dryness and smooth intestines. Abelmoschus manihot can inhibit myocardial lipid peroxidation and myocardial inflammatory reaction and protect myocardial cells.
And (3) dogbane leaf: sweet, bitter and cool. It enters liver meridian. Pacify liver, tranquilize mind, clear heat and induce diuresis. Folium Apocyni Veneti can increase cardiac glycogen resynthesis, treat cardiovascular function deficiency, relieve acute circulatory disturbance symptom of myocarditis, and prevent myocardial and coronary arteriosclerosis.
Mistletoe: sweet; bitter; the nature is mild. Dispelling wind-damp; strengthening bones and muscles; nourishing liver and kidney; promoting blood circulation to arrest pain; preventing miscarriage; and (4) feeding milk. Treating arrhythmia caused by myocarditis sequela, and promoting specific and nonspecific immunity.
Achyranthes aspera: sweet in taste; slightly bitter; micro-acid; is cold in nature. Liver diseases entering; the kidney channel. Promoting blood circulation and removing blood stasis; purging pathogenic fire and removing toxic substances; induce diuresis to treat stranguria. Treating viral myocarditis.
Evergreen: bitter, sweet and cold in taste. Has little toxicity. Entering the lung; the heart meridian. Clearing away heat and toxic materials, tonifying heart, and promoting urination; cool blood and stop bleeding. Treating viral myocarditis.
The invention is prepared from Chinese traditional herbal medicines, and the traditional Chinese medicine composition for treating myocarditis is combined by orderly matching certain natural extracts with definite components and clear effects according to a plurality of principles of traditional Chinese medicine treatment based on syndrome differentiation and modern medicine.
The traditional Chinese medicine composition has the effects of clearing heat and removing toxicity, promoting blood circulation to remove blood stasis, tonifying middle-jiao and Qi, healing sore and promoting tissue regeneration, regulating qi to alleviate pain, and enhancing the immune function of a body, is used for treating myocarditis, is decocted by 100 plus 150ml of water for one dose per day and divided into two parts, and is taken in the morning and evening respectively, has a remarkable effect of treating myocarditis, treats both symptoms and root causes, is quick in effect, good in effect after healing, safe, reliable, free of obvious toxic and side effects, does not hurt the spleen and stomach, and is convenient for a patient to take for a long time.
The traditional Chinese medicine composition has the advantages of small number of medicines, easily obtained raw materials, simple process, low cost and high efficiency, and is beneficial to pharmaceutical enterprises to carry out medicine production and quality control; the product has low price and is easy to be accepted by patients.
The treatment cost of the invention is relatively low and is far lower than that of western medicine.
The invention also provides an oral preparation prepared from the traditional Chinese medicine composition for treating myocarditis, which comprises oral liquid, tablets, capsules, pills and the like, wherein the preferable dosage forms are tablets and capsules, and one dose is taken every day in the morning and at night.
The traditional Chinese medicine composition can be prepared into various dosage forms. For example, the decocted liquid medicine is sterilized and disinfected and then packaged to prepare oral liquid; or concentrating the decoction, oven drying, adding pharmaceutically acceptable adjuvants, and making into tablet, capsule, pill, etc.
The medically acceptable auxiliary materials comprise starch, dextrin, sodium carboxymethylcellulose, polyethylene glycol, calcium hydrophosphate, sodium alginate, potassium sorbate and the like.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the present invention in any way, and it will be apparent to those skilled in the art that the above description of the present invention can be applied to various modifications, equivalent variations or modifications without departing from the spirit and scope of the present invention.
Claims (4)
1. A traditional Chinese medicine composition for treating myocarditis is characterized by comprising the following components in parts by weight: 3-9 parts of evergreen; 6-12 parts of dogbane leaves; 9-18 parts of achyranthes aspera and abelmoschus manihot; 15-30 parts of mistletoe.
2. The traditional Chinese medicine for treating myocarditis according to claim 1, which is characterized by comprising the following raw material medicines in parts by weight: 9 parts of evergreen; 12 parts of dogbane leaves; 18 parts of achyranthes aspera and abelmoschus manihot; 15-30 parts of mistletoe.
3. An oral preparation for treating myocarditis, which is prepared from the traditional Chinese medicine composition of any one of claims 1 or 2.
4. An oral formulation for the treatment of myocarditis according to claim 3, comprising an oral liquid, tablet, capsule, pill, preferably capsule and tablet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010464487.4A CN111419970A (en) | 2020-05-28 | 2020-05-28 | Traditional Chinese medicine composition for treating myocarditis |
CN2020104644874 | 2020-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113144076A true CN113144076A (en) | 2021-07-23 |
Family
ID=71553169
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010464487.4A Pending CN111419970A (en) | 2020-05-28 | 2020-05-28 | Traditional Chinese medicine composition for treating myocarditis |
CN202110561632.5A Withdrawn CN113144076A (en) | 2020-05-28 | 2021-05-23 | Traditional Chinese medicine composition for treating myocarditis |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010464487.4A Pending CN111419970A (en) | 2020-05-28 | 2020-05-28 | Traditional Chinese medicine composition for treating myocarditis |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN111419970A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111419970A (en) * | 2020-05-28 | 2020-07-17 | 仲崇允 | Traditional Chinese medicine composition for treating myocarditis |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111419970A (en) * | 2020-05-28 | 2020-07-17 | 仲崇允 | Traditional Chinese medicine composition for treating myocarditis |
-
2020
- 2020-05-28 CN CN202010464487.4A patent/CN111419970A/en active Pending
-
2021
- 2021-05-23 CN CN202110561632.5A patent/CN113144076A/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111419970A (en) * | 2020-05-28 | 2020-07-17 | 仲崇允 | Traditional Chinese medicine composition for treating myocarditis |
Also Published As
Publication number | Publication date |
---|---|
CN111419970A (en) | 2020-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102920806B (en) | Nerve-soothing blood-pressure-reducing traditional Chinese medicine tea | |
CN108524673A (en) | A kind of Chinese medicine composition and its application | |
CN113144076A (en) | Traditional Chinese medicine composition for treating myocarditis | |
CN102805807B (en) | Traditional Chinese medical composition for treating coronary heart disease and preparation method and applications thereof | |
CN113181258A (en) | A Chinese medicinal composition for treating menoxenia, dysmenorrhea, and amenorrhea | |
CN102973841A (en) | Traditional Chinese medicine used for treating arthromeningitis | |
CN103520652B (en) | Traditional Chinese medicine composition for treating liver cancer | |
CN102988747B (en) | Aristida triseta electuary for reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof | |
CN106581585A (en) | Medicine composition for treating gastric ulcer | |
CN113171414A (en) | A Chinese medicinal composition for treating coronary heart disease and angina pectoris | |
CN101152223A (en) | Use of poplar leaf phenols extract in treating cardiovascular disease and extracting method thereof | |
CN105193993B (en) | A kind of Chinese medicine composition with blood fat reducing function and preparation method thereof and purposes | |
CN106620253B (en) | Traditional Chinese medicine composition for treating bradyarrhythmia | |
CN104524461A (en) | Medicine composition for treating myocarditis and application thereof | |
CN111514236A (en) | Traditional Chinese medicine composition for treating myocardial infarction (infarction) | |
CN111714601A (en) | A Chinese medicinal composition for treating fungal infection | |
CN111759960A (en) | Traditional Chinese medicine composition for miscarriage prevention | |
CN105125985A (en) | Chinese and western medicine compound preparation for treating senile chronic bronchitis and preparation method thereof | |
CN111544470A (en) | Traditional Chinese medicine composition for treating heart failure | |
CN111759908A (en) | Traditional Chinese medicine composition for treating urticaria | |
CN113599423A (en) | Traditional Chinese medicine composition for treating anemia | |
CN111759936A (en) | A Chinese medicinal composition for treating dermatoses | |
CN113648392A (en) | Traditional Chinese medicine composition for treating cerebral infarction | |
CN116077568A (en) | Traditional Chinese medicine composition for treating abdominal mass | |
CN116077589A (en) | Traditional Chinese medicine composition for treating senile dementia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20210723 |